Pfizer stock jumps, Moderna, Merck tumble
Pfizer stock jumps, Moderna, Merck tumble Pfizer's stock soared after it delivered groundbreaking results for its COVID-19 oral antiviral candidate, PAXLOVID.
Please subscribe for more information and updates.